Table 1 The characteristics of studies that entered into the meta-analysis
First author | Country | Publication year | Period assessment | Sex | Age | Measuring tools | Sample size | Sampling method | Duration of infertility | Outcome (prevalence of depression (%) or mean score) |
|---|---|---|---|---|---|---|---|---|---|---|
Ahmadi [17] | Tehran | 2011 | 2008–2009 | Male | 34.1 ± 7.1 | BDI | 114 |  | 7 ± 6 | Sever, 42.5; mild, 57 |
Rahmati [18] | Ilam | 2019 | 2017 | Female | 35.91 (6.01) | BDI | 200 | Random | 10.84 ± 6.20 | Sever, 42; moderate, 19.5; mild, 14.5 |
Shahraki [19] | Tehran | 2018 | 2015–2017 | Female | 32.9 ± 7.2 | BDI | 115 | - | - | 13 ± 9.1 |
Shahraki [19] | Tehran | 2018 | 2015–2017 | Female | 31.3 ± 6.2 | BDI | 78 | - | - | 16.3 ± 8.7 |
Shahraki [19] | Tehran | 2018 | 2015–2017 | Female | 32.4 ± 5.4 | BDI | 71 | - | - | 16 ± 10.4 |
Omani-Samani [20] | Tehran | 2018 | 2017 | Male and female | 32.68 ± 5.54 | Patient Health Questionnaire-9 (PHQ-9). | 1506 | Random | 5.27 ± 3.95 | 7.05 ± 6.03; prevalence, 30.5 |
Maroufizadeh [21] | Tehran | 2018 | 2017 | Male | 34.31 ± 5.01 | PHQ-9 | 180 | Convenience | 4.83 ± 3.61 | 4.82 ± 5.47 |
Maroufizadeh [21] | Tehran | 2018 | 2017 | Female | 30.54 ± 5.39 | PHQ-9 | 180 | Convenience | 4.83 ± 3.61 | 6.76 ± 5.78 |
Maroufizadeh [22] | Tehran | 2018 | 2014–2015 | Male and female | 31.37 ± 5.69 | Hospital Anxiety and Depression Scale (HADS) | 1128 (479 male, 649 female) | - | 5.62 ± 4.03 | 5.99 ± 3.76; prevalence, 33 |
Basharpoor [23] | Tabriz | 2017 | 2015 | Female | Range 25–40 | Cognitive Emotion Regulation Questionnaire (CERQ) | 322 | Random | - | 45.22 ± 11.58 |
Samani [24] | Tehran | 2017 | 2013–2014 | Male | 32.94 ± 4.74 | DASS | 180 | - | - | Slight, 18.3; moderate, 8.3; sever, 5; very sever, 5 |
Samani [24] | Tehran | 2017 | 2013–2014 | Female | 29.39 ± 5.09 | DASS | 180 | - | - | Slight, 15; moderate, 21.7; sever, 6.7; very sever, 5 |
Omani Samani [25] | Tehran | 2017 | 2014–2015 | Male and female | 31.95 ± 5.59 | HADS | 312 | Convenience | 6.39 ± 4.55 | 6.06 ± 3.63 |
Navid [26] | Tehran | 2017 | 2014–2015 | Male | 33.25 ± 5.70 | HADS | 248 | Voluntary | 4.82 ± 3.50 | 5.50 ± 3.63 |
Navid [26] | Tehran | 2017 | 2014–2015 | Female | 29.15 ± 5.28 | HADS | 248 | Voluntary | 4.82 ± 3.50 | 6.65 ± 4.09 |
Karimzadeh [27] | Tehran | 2017 | 2014–2015 | Female | 28.3 ± 5.96 | The Symptom Checklist-90-Revised (SCL-90-R) | 78 | Convenience | 5.9 ± 4.19 | 1.44 ± 0.94 |
Karimzadeh [27] | Tehran | 2017 | 2014–2015 | Male | 31.68 ± 3.43 | The Symptom Checklist-90-Revised (SCL-90-R) | 50 | Convenience | 5.5 ± 2.76 | 1.18 ± 0.73 |
Amini [28] | Tehran | 2017 | 2014–2015 | Male and Female | 31.16 ± 5.87 | HADS | 651 | Random | 5.16 ± 3.77 | 5.96 ± 3.82 |
Dadi pour [29] | Bandarabbas | 2016 | - | Female | - | Goldberg and hiller questioner (GHQ -28) | 100 | Convenience | - | 16.46 ± 4.45 |
Shahverdi [30] | Kermanshah | 2015 | - | Female | - | Goldberg and hiller questioner (GHQ -28) | 100 | Convenience | - | 12.10 ± 5.08 |
Maroufizadeh [31] | Tehran | 2015 | 2013–2014 | Male and female | 33.9 ± 5.3 in male, 30.3 ± 5.4 in female | HADS | 330 | - | 6.2 ± 4.1 | 5.95 ± 3.54; mild, 21.2; moderate, 8.5; sever, 1.2 |
Maroufizadeh [31] | Tehran | 2015 | 2013–2014 | Male | 33.9 ± 5.3 | HADS | 122 | - | 6.2 ± 4.1 | 5.98 ± 3.58; mild, 24.6; moderate, 9.0; sever, 0.8 |
Maroufizadeh [31] | Tehran | 2015 | 2013–2014 | Female | 30.3 ± 5.4 | HADS | 208 | - | 6.2 ± 4.1 | 5.93 ± 3.52; mild, 19.2; moderate, 8.2; sever, 1.4 |
Hasanpour [32] | Tabriz | 2014 | 2012–2013 | Female | 29.64 ± 5.98 | GHQ | 345 | Convenience | 4 (2–7) | 3.58 ± 4.11 |
Zamani [33] | Kerman | 2013 | 2012 | Female | - | BDI | 30 | Convenience | - | 24.7 ± 6.16 |
Zarei [34] | Tehran | 2013 | 2012 | Female | 29.8 | DASS-42 | 137 | Convenience | - | 8.72 ± 7.78 |
Zarei [34] | Tehran | 2013 | 2012 | Female | 29.8 | DASS-42 | 137 | Convenience | - | 7.9 ± 7.06 |
Zarei [34] | Tehran | 2013 | 2012 | Female | 29.8 | DASS-42 | 137 | Convenience | - | 7.51 ± 6.76 |
Pakpour [35] | Zaheda, Ahvaz, Qazvin, Tehran, Gilan | 2012 | 2011–2012 | Female | 30.22 ± 7.68 | HADS | 410 | - | - | Prevalence, 46; 6.6 ± 2.4 |
Pakpour [35] | Zaheda, Ahvaz, Qazvin, Tehran, Gilan | 2012 | 2011–2012 | Female | 29.75 ± 8.06 | HADS | 194 | - | - | Prevalence, 41; 6.2 ± 2.2 |
Tamannai Far [36] | Kashan | 2011 | 2008 | Female | - | GHQ-28 | 65 | Random | - | 13.1 ± 3.50 |
Peyvandi [37] | Sari | 2011 | 2008 | Female | 28 | BDI | 200 | - | - | Total, 62; mild, 27.5; moderate, 27.5; sever, 9 |
Haririan [38] | Orumieh | 2010 | 2009 | Female | 27.5 ± 4.4 | BDI | 100 | - | 7.01 ± 4.45 | Total, 58; mild, 37; moderate, 10; sever, 11 |
Noorbala [39] | Tehran | 2009 | 2005–2006 | Female | 27.7 ± 5.2 | SCL-90-R | 150 | consecutive | 6.1 ± 4.4 | 1.30 ± 0.70 |
Faraji [40] | Rasht | 2009 | 2005 | Female | 28.19 ± 5.77 | BDI | 150 | - | - | Mild, 49.3; moderate, 7.3; Sever, 7 |
Farzadi [41] | Tabriz | 2008 | 2006 | Female | 27.3 ± 5.6 | BDI | 193 | Census | 4.1 ± 3.01 | Total, 72.54%; mild, 30.05; moderate, 30.0; sever, 10.88 |
Sadeghin [42] | Hamadan | 2006 | 2004 | Male | 30.56 ± 6.4 | SCL90 | 200 | Available | 7–21 | 6.87 ± 0.62; mild, 17.58; moderate, 3.01; sever, 2.51 |
Sadeghin [42] | Hamadan | 2006 | 2004 | Female | 30.56 ± 6.4 | SCL90 | 200 | Available | 7–21 | 12.24 ± 0.72; mild, 27; moderate, 13.5; sever, 9 |
Bahdani [43] | Mashhad | 2005 | - | Female | 27.68 ± 4.41 | BDI | 200 | Simple | - | Total, 57.1; mild, 36.3; moderate, 9.9; sever, 11 |
Yassini [44] | Yazd | 2005 | - | Female | - | BDI | 50 | - | - | Mild, 48; moderate, 21.3; sever, 16 |
Yassini [44] | Yazd | 2005 | - | Female | - | BDI | 25 | - | - | Mild, 44; moderate, 32; sever, 16 |
Yassini [44] | Yazd | 2005 | - | Female | - | BDI | 25 | - | - | Mild, 40; moderate, 24; sever, 28 |
Noruzinejad [45] | Qom | 2016 | 2013 | Male | 32.5 ± 5.5 | BDI | 136 | Available | 3.6 ± 3.3 | Total 16.9; mild, 52.2; moderate, 30.4; sever, 17.4 |
Behjati Ardakani [46] | Tehran | 2011 | 2006–2007 | Male and female | 34 ± 6 | GHQ-28 | 400 | Purpose-based sampling | - | 3.3 |
Behjati Ardakani [46] | Tehran | 2011 | 2006–2007 | Female | 34 ± 6 | GHQ-28 | 399 | Purpose-based sampling | - | 4.5 |
Behjati Ardakani [46] | Tehran | 2011 | 2006–2007 | Male | 34 ± 6 | GHQ-28 | 398 | Purpose-based sampling | - | 2 |
Sotoudeh [47] | Tehran | 2008 | 2000–2001 | Female | - | BDI | 55 | Simple | - | 21.88 ± 6.52 |